Growth Metrics

Gilead Sciences (GILD) Income towards Parent Company (2016 - 2026)

Gilead Sciences filings provide 17 years of Income towards Parent Company readings, the most recent being $2.5 billion for Q4 2025.

  • On a quarterly basis, Income towards Parent Company rose 41.86% to $2.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $8.9 billion, a 1748.85% increase, with the full-year FY2025 number at $8.5 billion, up 1676.62% from a year prior.
  • Income towards Parent Company hit $2.5 billion in Q4 2025 for Gilead Sciences, down from $3.1 billion in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $3.1 billion in Q3 2025 to a low of -$4.2 billion in Q1 2024.
  • Median Income towards Parent Company over the past 5 years was $1.6 billion (2021), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Income towards Parent Company: soared 8100.0% in 2023 and later tumbled 523.88% in 2024.
  • Gilead Sciences' Income towards Parent Company stood at $376.0 million in 2021, then surged by 334.31% to $1.6 billion in 2022, then fell by 13.29% to $1.4 billion in 2023, then grew by 25.85% to $1.8 billion in 2024, then surged by 41.86% to $2.5 billion in 2025.
  • The last three reported values for Income towards Parent Company were $2.5 billion (Q4 2025), $3.1 billion (Q3 2025), and $2.0 billion (Q2 2025) per Business Quant data.